JANET BAUMANN: Open Payments
NPI 1053750315 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$680 in 9 payments from 7 companies in 2025. Trend: 2023 $29 · 2024 $14 · 2025 $680
Food & beverage: $680
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $177 |
| GlaxoSmithKline, LLC. | 1 | $121 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $113 |
| AKEBIA THERAPEUTICS INC | 1 | $113 |
| Vantive US Healthcare LLC | 1 | $87 |
| Calliditas Therapeutics US Inc. | 2 | $44 |
| Travere Therapeutics, Inc. | 1 | $25 |
Products named: LOKELMA, Kerendia, Vafseo, Renal - Acute, FARXIGA, TARPEYO.
Industry payments across AL — which companies pay providers there.
